Jose-Maria Fernandez: Financial engineering for good: A New Approach to Funding Large-Scale Biomedical Innovation

MIT Sloan Researcher Jose-Maria Fernandez

There is a growing consensus that the “bench-to-bedside” process of translating biomedical research into effective therapeutics is broken. A confluence of factors explains such pessimism but among the most widespread is the sense that the current the drug development business model is flawed. The development of new therapeutics is an expensive, lengthy, and risky process that challenges traditional funding vehicles, which are limited in size, Read More »